Sign in

CIK 0000885590

  • Large accelerated filer

Bausch Health Companies Inc.

Sign in to watch
Ticker
BHC
Exchange
NYSE
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
NJ
Entity type
Operating
Phone
+1 514-744-6792
Business address
2150 ST. ELZEAR BLVD. WEST, LAVAL, QUEBEC, Quebec, Canada, H7L 4A8
Former names
Valeant Pharmaceuticals International, Inc., BIOVAIL Corp, BIOVAIL CORP INTERNATIONAL, BIOVAIL CORPORATION INTERNATIONAL
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2017-03-14 Pershing Square Capital Management, L.P. Director Sale · Call Option (call equivalent position) −91,200 $0.30 $27K 0
2017-03-13 Pershing Square Capital Management, L.P. Director Sale −18,114,432 $11.00 $199.3M 0
2017-03-13 Pershing Square Capital Management, L.P. Director Purchase · Put Option (call equivalent position) −9,120,000 $47.65 $434.6M 0
2016-12-12 Pershing Square Capital Management, L.P. Director Sale −3,476,690 $14.85 $51.6M 18,114,432
2016-12-12 Pershing Square Capital Management, L.P. Director Purchase · Call Option (put equivalent position) +9,120,000 $0.01 $91K 0
2016-06-09 Pershing Square Capital Management, L.P. Director Purchase · Put Option (call equivalent position) −9,120,000 $35.80 $326.5M 0
2016-06-09 Pershing Square Capital Management, L.P. Director Sale · Call Option (call equivalent position) −9,120,000 $0.03 $274K 0
2016-06-09 Pershing Square Capital Management, L.P. Director Purchase · Call Option (call equivalent position) +91,200 $4.00 $365K 91,200
2016-06-09 Pershing Square Capital Management, L.P. Director Sale · Put Option (call equivalent position) +9,120,000 $37.09 $338.3M 9,120,000

Page 1 of 1 · 9 trades